Manami Shimomura

Author PubWeight™ 7.88^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma.	Cancer Sci	2009	1.64
2	Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression.	Cancer Lett	2009	1.07
3	Growth inhibition by NVP-BEZ235, a dual PI3K/mTOR inhibitor, in hepatocellular carcinoma cell lines.	Oncol Rep	2011	1.00
4	Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function.	Stem Cells	2007	0.98
5	Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.	Cancer Immunol Immunother	2012	0.91
6	Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide.	Int J Oncol	2013	0.83
7	Identification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, Lengsin.	Int J Oncol	2011	0.82
8	Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican‑3‑derived peptide.	Int J Oncol	2013	0.81